Cellusion Inc. announced that it has received ¥1.1 billion in funding from a group of investors
December 30, 2021
Share
In December 2021, Cellusion Inc. closed the transaction. The company has raised ¥1,100 million in a round of funding co-led by returning investors, DBJ Capital Co., Ltd., Keio Innovation Initiative Inc., SMBC Venture Capital Co., Ltd. The transaction also included participation from new investors, Gemseki Inc., Investment Arm, Toyo Seikan Group Holdings, Ltd., The University of Tokyo Edge Capital Co., Ltd., and Toho Holdings Co., Ltd. The company has raised a total of ¥1,700 million in funding till date. The company issued common shares in the transaction.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
TOHO HOLDINGS CO., LTD. 
